ENSG00000105852


Homo sapiens

Features
Gene ID: ENSG00000105852
  
Biological name :PON3
  
Synonyms : paraoxonase 3 / PON3 / Q15166
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 7
Strand: -1
Band: q21.3
Gene start: 95359944
Gene end: 95396368
  
Corresponding Affymetrix probe sets: 213695_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000393174
Ensembl peptide - ENSP00000413276
Ensembl peptide - ENSP00000403850
Ensembl peptide - ENSP00000265627
Ensembl peptide - ENSP00000390253
Ensembl peptide - ENSP00000391072
NCBI entrez gene - 5446     See in Manteia.
OMIM - 602720
RefSeq - NM_000940
RefSeq Peptide - NP_000931
swissprot - F8WD41
swissprot - C9JZ99
swissprot - Q15166
swissprot - F2Z2L3
swissprot - F8WBV4
Ensembl - ENSG00000105852
  
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 pon1ENSDARG00000032496Danio rerio
 pon2ENSDARG00000016856Danio rerio
 pon3.2ENSDARG00000097789Danio rerio
 pon3.2ENSDARG00000040290Danio rerio
 PON2ENSGALG00000009689Gallus gallus
 Pon3ENSMUSG00000029759Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
PON2 / Q15165 / paraoxonase 2ENSG0000010585465
PON1 / P27169 / paraoxonase 1ENSG0000000542161


Protein motifs (from Interpro)
Interpro ID Name
 IPR002640  Arylesterase
 IPR008364  Paraoxonase2
 IPR011042  Six-bladed beta-propeller, TolB-like


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0009636 response to toxic substance IBA
 biological_processGO:0010124 phenylacetate catabolic process IEA
 biological_processGO:0016311 dephosphorylation IEA
 biological_processGO:0019372 lipoxygenase pathway TAS
 biological_processGO:0019439 aromatic compound catabolic process IDA
 biological_processGO:0032929 negative regulation of superoxide anion generation IEA
 biological_processGO:0046226 coumarin catabolic process IEA
 biological_processGO:0046395 carboxylic acid catabolic process IDA
 cellular_componentGO:0005576 extracellular region TAS
 cellular_componentGO:0005615 extracellular space IBA
 cellular_componentGO:0043231 intracellular membrane-bounded organelle IEA
 cellular_componentGO:0070062 extracellular exosome HDA
 molecular_functionGO:0004063 aryldialkylphosphatase activity IEA
 molecular_functionGO:0004064 arylesterase activity IEA
 molecular_functionGO:0016787 hydrolase activity IEA
 molecular_functionGO:0018733 3,4-dihydrocoumarin hydrolase activity IEA
 molecular_functionGO:0042803 protein homodimerization activity IDA
 molecular_functionGO:0046872 metal ion binding IEA
 molecular_functionGO:0047856 dihydrocoumarin hydrolase activity IEA
 molecular_functionGO:0102007 acyl-L-homoserine-lactone lactonohydrolase activity TAS


Pathways (from Reactome)
Pathway description
Synthesis of 5-eicosatetraenoic acids


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000217 Xerostomia "Dryness of the mouth due to salivary gland dysfunction." [HPO:curators]
Show

 HP:0000712 Emotional lability 
Show

 HP:0000713 Agitation 
Show

 HP:0000716 Depression "A condition characterized by pervasive dysphoric mood, loss of interests, and inability to experience pleasure." [HPO:curators]
Show

 HP:0000739 Anxiety 
Show

 HP:0001257 Spasticity "A motor disorder characterized by a velocity-dependent increase in tonic stretch reflexes with increased muscle tone, exaggerated (hyperexcitable) tendon reflexes." [HPO:curators]
Show

 HP:0002017 Nausea and vomiting 
Show

 HP:0002094 Dyspnea 
Show

 HP:0002180 Neurodegeneration 
Show

 HP:0002878 Early respiratory failure 
Show

 HP:0003202 Amyotrophy "The presence of muscular atrophy (which is also known as amyotrophy)." [HPO:curators]
Show

 HP:0003324 Generalized muscle weakness "Generalized weakness or decreased strength of the muscles." [HPO:curators]
Show

 HP:0003394 Muscle cramps 
Show

 HP:0003470 Paralysis "Paralysis of voluntary muscles means loss of contraction due to interruption of one or more motor pathways from the brain to the muscle fibers. Although the word paralysis is often used interchangeably to mean either complete or partial loss of muscle strength, it is preferable to use paralysis or plegia for complete or severe loss of muscle strength, and paresis for partial or slight loss. Motor paralysis results from deficits of the upper motor neurons (corticospinal, corticobulbar, or subcorticospinal). Motor paralysis is often accompanied by an impairment in the facility of movement." [HPO:curators]
Show

 HP:0005945 Laryngeal obstruction 
Show

 HP:0007354 Amyotrophic lateral sclerosis 
Show

 HP:0012378 Fatigue "A subjective feeling of tiredness characterized by a lack of energy and motivation." [HPO:probinson]
Show

 HP:0012531 Pain "An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage." [ORCID:0000-0001-5208-3432]
Show

 HP:0030195 Fatigable weakness of swallowing muscles "A type of weakness of the muscles involved in swallowing that occurs after a muscle group is used and lessens if the muscle group has some rest. That is, there is diminution of strength with repetitive muscle actions." [pmid:17986328, UK:rheller]
Show

 HP:0030196 Fatigable weakness of respiratory muscles "A type of weakness of the muscles involved in breathing (respiration) that occurs after a muscle group is used and lessens if the muscle group has some rest. That is, there is diminution of strength with repetitive muscle actions." [UNCL:mbertoli]
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
 ENSG00000105852 PON3 / Q15166 / paraoxonase 3  / complex






 

0 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr